🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 13/06/2011 | 0,3626 USD |
| 11/03/2011 | 0,3626 USD |
| 13/12/2010 | 0,3626 USD |
| 13/09/2010 | 0,3626 USD |
| 11/06/2010 | 0,3626 USD |
| 11/03/2010 | 0,3626 USD |
| 11/12/2009 | 0,3626 USD |
| 02/09/2009 | 0,3626 USD |
| 04/06/2009 | 0,3626 USD |
| 04/03/2009 | 0,3626 USD |
| 03/12/2008 | 0,3626 USD |
| 03/09/2008 | 0,3626 USD |
| 04/06/2008 | 0,3626 USD |
| 05/03/2008 | 0,3626 USD |
| 05/12/2007 | 0,3626 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 28/03/2002 | 54,78 | 55,06 | 54,63 | 54,94 | +0,30% | 0,78% | 6.613.404 |
| 27/03/2002 | 54,72 | 54,87 | 54,37 | 54,78 | +0,02% | 0,91% | 5.765.991 |
| 26/03/2002 | 54,96 | 55,34 | 54,53 | 54,77 | -0,19% | 1,48% | 5.974.543 |
| 25/03/2002 | 55,23 | 55,89 | 54,88 | 54,88 | -1,19% | 1,83% | 7.057.651 |
| 22/03/2002 | 55,06 | 56,18 | 55,06 | 55,53 | +0,26% | 2,04% | 5.629.646 |
| 21/03/2002 | 55,43 | 55,52 | 54,68 | 55,39 | -0,05% | 1,51% | 6.292.506 |
| 20/03/2002 | 55,74 | 56,25 | 55,08 | 55,42 | -0,58% | 2,11% | 10.064.049 |
| 19/03/2002 | 56,56 | 56,56 | 55,58 | 55,74 | -0,63% | 1,74% | 9.058.912 |
| 18/03/2002 | 56,55 | 56,97 | 55,83 | 56,10 | -1,61% | 2,01% | 13.601.258 |
| 15/03/2002 | 58,11 | 58,21 | 56,81 | 57,01 | -5,82% | 2,40% | 28.237.102 |
| 14/03/2002 | 60,93 | 61,36 | 60,43 | 60,53 | -1,44% | 1,52% | 4.040.040 |
| 13/03/2002 | 60,35 | 61,55 | 60,27 | 61,42 | +1,39% | 2,12% | 7.334.323 |
| 12/03/2002 | 59,66 | 60,64 | 59,17 | 60,58 | +1,20% | 2,46% | 4.151.023 |
| 11/03/2002 | 59,76 | 60,18 | 59,20 | 59,87 | +0,38% | 1,64% | 3.878.229 |
| 08/03/2002 | 60,28 | 60,58 | 59,35 | 59,64 | -1,06% | 2,04% | 4.676.386 |
| 07/03/2002 | 59,80 | 60,48 | 58,86 | 60,28 | +0,80% | 2,70% | 4.874.248 |
| 06/03/2002 | 59,06 | 60,12 | 59,02 | 59,80 | +1,39% | 1,87% | 5.101.978 |
| 05/03/2002 | 59,88 | 60,09 | 58,98 | 58,98 | -1,90% | 1,85% | 5.888.398 |
| 04/03/2002 | 59,87 | 60,37 | 59,35 | 60,12 | +0,05% | 1,71% | 5.961.129 |
| 01/03/2002 | 58,55 | 60,10 | 58,50 | 60,10 | +2,69% | 2,72% | 5.145.890 |
| 28/02/2002 | 57,87 | 58,91 | 57,87 | 58,52 | +0,74% | 1,80% | 4.860.624 |
| 27/02/2002 | 58,32 | 59,62 | 57,60 | 58,09 | +0,38% | 3,47% | 7.413.133 |
| 26/02/2002 | 58,04 | 58,67 | 57,50 | 57,87 | -0,31% | 2,02% | 5.393.532 |
| 25/02/2002 | 58,34 | 58,59 | 57,62 | 58,05 | -1,07% | 1,65% | 6.214.221 |
| 22/02/2002 | 57,82 | 59,09 | 57,76 | 58,68 | +0,80% | 2,31% | 6.151.550 |
| 21/02/2002 | 58,45 | 59,26 | 58,19 | 58,22 | -0,41% | 1,83% | 7.516.675 |
| 20/02/2002 | 56,55 | 58,66 | 56,36 | 58,45 | +3,39% | 4,08% | 7.617.807 |
| 19/02/2002 | 56,42 | 57,01 | 56,20 | 56,54 | -0,94% | 1,44% | 4.251.946 |
| 15/02/2002 | 56,96 | 57,21 | 56,56 | 57,07 | +0,20% | 1,16% | 7.360.104 |
| 14/02/2002 | 57,29 | 57,40 | 56,44 | 56,96 | -1,47% | 1,67% | 6.589.719 |